Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Lucid Diagnostics (LUCD) Receivables - Other (2021 - 2023)

Lucid Diagnostics' Receivables - Other history spans 3 years, with the latest figure at $10.7 million for Q2 2023.

  • For Q2 2023, Receivables - Other rose 340.39% year-over-year to $10.7 million; the TTM value through Jun 2023 reached $10.7 million, up 340.39%, while the annual FY2022 figure was $5.0 million, 199.34% up from the prior year.
  • Receivables - Other reached $10.7 million in Q2 2023 per LUCD's latest filing, up from $7.6 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $10.7 million in Q2 2023 to a low of $1.7 million in Q4 2021.
  • Average Receivables - Other over 3 years is $5.1 million, with a median of $5.0 million recorded in 2022.
  • Peak YoY movement for Receivables - Other: soared 199.34% in 2022, then soared 340.39% in 2023.
  • A 3-year view of Receivables - Other shows it stood at $1.7 million in 2021, then skyrocketed by 199.34% to $5.0 million in 2022, then surged by 115.67% to $10.7 million in 2023.
  • Per Business Quant, the three most recent readings for LUCD's Receivables - Other are $10.7 million (Q2 2023), $7.6 million (Q1 2023), and $5.0 million (Q4 2022).